{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T03:22:05Z","timestamp":1772767325480,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ajog.2008.12.035","type":"journal-article","created":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T04:10:41Z","timestamp":1235880641000},"page":"219-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Progesterone for preterm birth prevention: an evolving intervention"],"prefix":"10.1016","volume":"200","author":[{"given":"Alan Thevenet N.","family":"Tita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight J.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2008.12.035_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2008.12.035_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJMoa0706475","article-title":"Long-term medical and social consequences of preterm birth","volume":"359","author":"Moster","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.12.035_bib3","first-page":"1","article-title":"Centers for Disease Control and Prevention National Center for Health Statistics National Vital Statistics System births: final data for 2005","volume":"56","author":"Martin","year":"2007","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2008.12.035_bib4","first-page":"1115","article-title":"Use of progesterone to reduce preterm birth: ACOG committee opinion No. 2919","volume":"102","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1701-2163(16)32716-5","article-title":"The use of progesterone for prevention of preterm birth","volume":"30","author":"Farine","year":"2008","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2008.12.035_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1479-828X.2007.00803.x","article-title":"Progesterone for maintenance tocolytic therapy after threatened preterm labor: a randomized controlled trial","volume":"48","author":"Borna","year":"2008","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa070641","article-title":"A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins","volume":"357","author":"Rouse","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.12.035_bib8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.12.035_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/uog.5158","article-title":"Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"O'Brien","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/uog.5159","article-title":"Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial","volume":"30","author":"DeFranco","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib11","doi-asserted-by":"crossref","first-page":"453.e1","DOI":"10.1016\/j.ajog.2006.09.009","article-title":"Cervical length changes during preterm cervical ripening: effects of a 17-a-hydrosyprogesterone caproate","volume":"196","author":"Facchinetti","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib12","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajog.2008.12.035_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mob.2003.41","article-title":"Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study","volume":"188","author":"da Fonseca","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/01.AOG.0000150559.59531.b2","article-title":"Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials","volume":"105","author":"Sanchez-Ramos","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib15","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.0001-6349.2005.00835.x","article-title":"Progesterone supplementation for preventing preterm birth: a systematic review and meta-analysis","volume":"84","author":"Dodd","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2008.12.035_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004947.pub2","article-title":"Prenatal administration of progesterone for preventing preterm birth [review]","volume":"2","author":"Dodd","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2008.12.035_bib17","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ajog.2005.06.049","article-title":"Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials","volume":"194","author":"Mackenzie","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejogrb.2006.05.013","article-title":"Progesterone for the prevention of preterm birth: a critical evaluation of evidence","volume":"129","author":"Coomarasamy","year":"2006","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2008.12.035_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/AOG.0b013e31817d0262","article-title":"Progesterone for the prevention of preterm birth","volume":"112","author":"Dodd","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/AOG.0b013e31818b1ff6","article-title":"Use of progesterone to reduce preterm birth: ACOG committee opinion No. 419","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0015-0282(16)56935-0","article-title":"Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study","volume":"62","author":"Miles","year":"1994","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ajog.2008.12.035_bib22","first-page":"403","article-title":"Direct transport of progesterone from vagina to uterus","volume":"95","author":"Cicinelli","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2008.12.035_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/01.AOG.0000281348.51499.bc","article-title":"National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network: follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo","volume":"110","author":"Northen","year":"2007","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937808024423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937808024423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:28:53Z","timestamp":1757586533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937808024423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S0002937808024423"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2008.12.035","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progesterone for preterm birth prevention: an evolving intervention","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2008.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}